col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


70 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Leukemia
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jul―23 Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group Anne Mea Spanjaart, Per Ljungman, Gloria Tridello, Juana Schwartz, Nuria Martinez-Cibrián, Pere Barba, et al. (+36)
2 [GO] 2023―Dez―04 Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients Julius C. Enssle, Julia Campe, Alina Moter, Isabel Voit, Alec Gessner, Weijia Yu, et al. (+15)
3 [GO] 2023―Jul―28 The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial J. Hammersen, S. Birndt, K. Döhner, P. Reuken, A. Stallmach, P. Sauerbrey, et al. (+12)
4 [GO] 2023―Jul―28 Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Ioannis Ntanasis-Stathopoulos, Pieter Sonneveld, Heinz Ludwig
5 [GO] 2023―Jul―17 Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) Simone Cesaro, Malgorzata Mikulska, Hans H. Hirsch, Jan Styczynski, Sylvain Meylan, Catherine Cordonnier, et al. (+14)
6 [GO] 2023―Jun―22 COVID-19 convalescent plasma retains value for immunocompromised patients Daniele Focosi, Massimo Franchini
7 [GO] 2023―Mai―04 Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, et al. (+15)
8 [GO] 2023―Apr―10 The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study Torsten Dahlén, Hjalmar Flygt, Anna Lübking, Ulla Olsson-Strömberg, Lovisa Wennström, Arta Dreimane, et al. (+7)
9 [GO] 2022―Dez―17 COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors Dragana Milojkovic, Catherine J. Reynolds, Diana Mūnoz Sandoval, Franziska P. Pieper, Siyi Liu, Corinna Pade, et al. (+9)
10 [GO] 2022―Okt―26 Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic Arndt Borkhardt, Joachim Schüz, Claudia Trübenbach, Maike Wellbrock, Claudia Spix, Friederike Erdmann
11 [GO] 2022―Aug―13 Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine M. Breccia, A. Piciocchi, M. Messina, S. Soddu, V. De Stefano, M. Bellini, et al. (+9)
12 [GO] 2022―Jun―27 Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period Natalia Neparidze, Rong Wang, Amer M. Zeidan, Nikolai A. Podoltsev, Rory M. Shallis, Xiaomei Ma, et al. (+2)
13 [GO] 2022―Apr―29 Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9) Simone Cesaro, Per Ljungman, Malgorzata Mikulska, Hans H. Hirsch, Marie von Lilienfeld-Toal, Catherine Cordonnier, et al. (+15)
14 [GO] 2022―Feb―25 Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients Joan How, Kathleen M. E. Gallagher, Yiwen Liu, Katelin Katsis, Eva L. Elder, Rebecca C. Larson, et al. (+4)
15 [GO] 2022―Feb―01 Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis Thomas Hueso, Anne-Sophie Godron, Emilie Lanoy, Jérôme Pacanowski, Laura I. Levi, Emmanuelle Gras, et al. (+15)
16 [GO] 2022―Jan―21 Second versus first wave of COVID-19 in patients with MPN Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, et al. (+49)
17 [GO] 2021―Dez―22 SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia Sibylle C. Mellinghoff, Sandra Robrecht, Leonie Mayer, Leonie M. Weskamm, Christine Dahlke, Henning Gruell, et al. (+10)
18 [GO] 2021―Nov―08 Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Anne Mea Spanjaart, Per Ljungman, Rafael de La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, et al. (+28)
19 [GO] 2021―Nov―05 Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines Kathryn E. Kozak, Linda Ouyang, Andriy Derkach, Alexandra Sherman, Susan J. McCall, Christopher Famulare, et al. (+5)
20 [GO] 2021―Nov―01 COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David Allsup, Alejandro Alonso Cabrero, et al. (+107)
21 [GO] 2021―Sep―25 Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients Lisa Blixt, Gordana Bogdanovic, Marcus Buggert, Yu Gao, Sophia Hober, Katie Healy, et al. (+13)
22 [GO] 2021―Sep―13 Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) Andreas Neubauer, Johannes Johow, Elisabeth Mack, Andreas Burchert, Damaris Meyn, Andrea Kadlubiec, et al. (+10)
23 [GO] 2021―Sep―07 The impact of specific cytokine directed treatment on severe COVID-19 P. A. Reuken, M. M. Rüthrich, A. Hochhaus, J. Hammersen, M. Bauer, P. La Rosée, et al. (+2)
24 [GO] 2021―Aug―12 The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) Andreas Neubauer, Johannes Johow, Elisabeth Mack, Andreas Burchert, Damaris Meyn, Andrea Kadlubiec, et al. (+10)
25 [GO] 2021―Jul―29 Response to mRNA vaccination for COVID-19 among patients with multiple myeloma Samuel D. Stampfer, Marissa-Skye Goldwater, Scott Jew, Sean Bujarski, Bernard Regidor, David Daniely, et al. (+12)
26 [GO] 2021―Jun―28 Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, Diego Ripamonti, Ivano Riva, Francesco Landi, et al. (+16)
27 [GO] 2021―Jun―23 An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner Magdalena Kucia, Janina Ratajczak, Kamila Bujko, Mateusz Adamiak, Andrzej Ciechanowicz, Vira Chumak, et al. (+2)
28 [GO] 2021―Jun―02 COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey Per Ljungman, Rafael de la Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Mohsen Al Zahrani, et al. (+24)
29 [GO] 2021―Mai―24 Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, Diego Ripamonti, Ivano Riva, Francesco Landi, et al. (+16)
30 [GO] 2021―Mai―22 Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, et al. (+14)
31 [GO] 2021―Mai―18 Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients Nikolay Mayanskiy, Polina Luchkina, Natalia Fedorova, Yuri Lebedin, Natalia Ponomareva
32 [GO] 2021―Mai―17 Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19) Chong-xiang Chen, Fang Hu, Jin Wei, Le-tao Yuan, Tian-meng Wen, Robert Peter Gale, Yang Liang
33 [GO] 2021―Mai―14 JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis Chong-xiang Chen, Jiao-jiao Wang, Huan Li, Le-tao Yuan, Robert Peter Gale, Yang Liang
34 [GO] 2021―Mai―13 COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia Lindsey E. Roeker, David A. Knorr, Meghan C. Thompson, Mariely Nivar, Sonia Lebowitz, Nicole Peters, et al. (+12)
35 [GO] 2021―Mai―04 Hairy cell leukemia and COVID-19 adaptation of treatment guidelines Michael Grever, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema Bhat, James S. Blachly, et al. (+33)
36 [GO] 2021―Mrz―17 Ruxolitinib withdrawal due to the COVID-19 Marko Lucijanic, Rajko Kusec
37 [GO] 2021―Feb―25 Response to: Ruxolitinib withdrawal due to the COVID-19 Tiziano Barbui, Alessandra Carobbio
38 [GO] 2021―Feb―20 Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection Philipp A. Reuken, Andreas Stallmach, Mathias W. Pletz, Christian Brandt, Nico Andreas, Sabine Hahnfeld, et al. (+4)
39 [GO] 2021―Feb―13 Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm Richard A. Salisbury, Natalia Curto-Garcia, Jennifer O’Sullivan, Frederick Chen, Paolo Polzella, Anna L. Godfrey, et al. (+31)
40 [GO] 2021―Jan―07 High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, et al. (+45)
41 [GO] 2020―Dez―09 SARS-CoV-2 antibody responses in patients with acute leukaemia J. O’Nions, L. Muir, J. Zheng, C. Rees-Spear, A. Rosa, C. Roustan, et al. (+6)
42 [GO] 2020―Nov―10 Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia A. D’Alessio, P. Del Poggio, F. Bracchi, G. Cesana, N. Sertori, D. Di Mauro, et al. (+7)
43 [GO] 2020―Okt―26 COVID-19 and myeloproliferative neoplasms: some considerations Baransel Kamaz, Ann Mullally
44 [GO] 2020―Sep―02 The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 Alessandro Gozzetti, Enrico Capochiani, Monica Bocchia
45 [GO] 2020―Aug―25 COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey Massimo Breccia, Alfonso Piciocchi, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Paola Fazi, et al. (+8)
46 [GO] 2020―Aug―19 Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study Alessandro M. Vannucchi, Benedetta Sordi, Alessandro Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, et al. (+22)
47 [GO] 2020―Aug―14 COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter Ankur Varma, Satyajit Kosuri, Celalettin Ustun, Uroosa Ibrahim, Jonathan Moreira, Michael R. Bishop, et al. (+6)
48 [GO] 2020―Aug―07 Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time Chiara Cattaneo, Chiara Pagani, Valeria Cancelli, Luisa Imberti, Aldo M. Roccaro, Luigi D. Notarangelo, Giuseppe Rossi
49 [GO] 2020―Aug―04 Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy Gianluigi Reda, Alessandro Noto, Ramona Cassin, Giulia Zamprogna, Chiara Borella, Lydia Scarfò, et al. (+5)
50 [GO] 2020―Jul―20 Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission Qiubai Li, Lei Chen, Qin Li, Wenjuan He, Jianming Yu, Li Chen, et al. (+13)
51 [GO] 2020―Jul―09 COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini, Marina Motta, Candida Vitale, et al. (+76)
52 [GO] 2020―Jul―08 Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study Geneviève I. C. G. Ector, Elisabeth G. W. Huijskens, Nicole M. A. Blijlevens, Peter E. Westerweel
53 [GO] 2020―Jul―08 Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands Jaap van Doesum, Anabelle Chinea, Maria Pagliaro, Maria Cristina Pasquini, Tom van Meerten, Martijn Bakker, Emanuele Ammatuna
54 [GO] 2020―Jul―03 How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey Francesca Palandri, Alfonso Piciocchi, Valerio De Stefano, Massimo Breccia, Guido Finazzi, Alessandra Iurlo, et al. (+8)
55 [GO] 2020―Jun―29 COVID-19 among fit patients with CLL treated with venetoclax-based combinations Moritz Fürstenau, Petra Langerbeins, Nisha De Silva, Anna Maria Fink, Sandra Robrecht, Julia von Tresckow, et al. (+16)
56 [GO] 2020―Jun―19 Impact of Covid-19 on the treatment of acute myeloid leukemia Felicetto Ferrara, Patrizia Zappasodi, Elisa Roncoroni, Erika Borlenghi, Giuseppe Rossi
57 [GO] 2020―Jun―18 Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey Massimo Breccia, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio, Fausto Castagnetti, Carmen Fava, et al. (+13)
58 [GO] 2020―Jun―18 Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia Julia Hauer, Ute Fischer, Franziska Auer, Arndt Borkhardt
59 [GO] 2020―Jun―17 Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) Andreas Neubauer, Thomas Wiesmann, Claus F. Vogelmeier, Elisabeth Mack, Chrysanthi Skevaki, Christine Gaik, et al. (+7)
60 [GO] 2020―Jun―16 Risk factors for death in 1859 subjects with COVID-19 Lei Chen, Jianming Yu, Wenjuan He, Li Chen, Guolin Yuan, Fang Dong, et al. (+15)
61 [GO] 2020―Jun―11 Hematological features of persons with COVID-19 Qiubai Li, Yulin Cao, Lei Chen, Di Wu, Jianming Yu, Hongxiang Wang, et al. (+13)
62 [GO] 2020―Jun―11 Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation F. Heidel, A. Hochhaus
63 [GO] 2020―Jun―09 The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation F. La Rosée, H. C. Bremer, I. Gehrke, A. Kehr, A. Hochhaus, S. Birndt, et al. (+5)
64 [GO] 2020―Jun―01 Multiple myeloma and COVID-19 Binod Dhakal, Anita D’Souza, Saurabh Chhabra, Parameswaran Hari
65 [GO] 2020―Jun―01 SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells Mariusz Z. Ratajczak, Magda Kucia
66 [GO] 2020―Mai―22 Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) Evangelos Terpos, Monika Engelhardt, Gordon Cook, Francesca Gay, Maria-Victoria Mateos, Ioannis Ntanasis-Stathopoulos, et al. (+12)
67 [GO] 2020―Mai―19 CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report Tycho Baumann, Julio Delgado, Emili Montserrat
68 [GO] 2020―Mai―05 Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis Huan Li, Chongxiang Chen, Fang Hu, Jiaojiao Wang, Qingyu Zhao, Robert Peter Gale, Yang Liang
69 [GO] 2020―Mai―01 Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases Marie von Lilienfeld-Toal, Jörg Janne Vehreschild, Oliver Cornely, Livio Pagano, Francesca Compagno, Hans H. Hirsch
70 [GO] 2020―Apr―24 COVID-19 in persons with haematological cancers Wenjuan He, Lei Chen, Li Chen, Guolin Yuan, Yun Fang, Wenlan Chen, et al. (+9)
 [1] 

70 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec